Combination pharmaceutical compositions comprising an activated-potentiated form of an antibody to endothelial NO synthase and activated potentiated form of an antibody to brain - specific protein S-100 and their use for the treatment of vegetative-vascular dystonia (VVD) and symptoms thereof.